Bank Julius Baer & Co
BIO icon

Bank Julius Baer & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bank Julius Baer & Co’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-217
Closed -$107K – 578
2022
Q2 		$107K Hold
217
– – ﹤0.01% 479
2022
Q1 		$122K Hold
217
– – ﹤0.01% 472
2021
Q4 		$164K Sell
217
-1,518
-87% -$1.14M ﹤0.01% 561
2021
Q3 		$1.29M Buy
1,735
+641
+59% +$480K 0.01% 300
2021
Q2 		$705K Buy
1,094
+818
+296% +$498K ﹤0.01% 402
2021
Q1 		$158K Sell
276
-1,570
-85% -$930K ﹤0.01% 573
2020
Q4 		$1.08M Buy
1,846
+737
+66% +$420K 0.01% 343
2020
Q3 		$572K Buy
1,109
+973
+715% +$493K 0.01% 365
2020
Q2 		$61K Buy
+136
New +$60K ﹤0.01% 554

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank Julius Baer & Co's BIO Position: Q3 2022 in Review

Bank Julius Baer & Co sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 217 shares — an estimated $107K sold.

Bank Julius Baer & Co first reported a position in BIO in Q2 2020 and held it in 9 quarters. The position peaked at $1.29M in Q3 2021. 484 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

  • Bank Julius Baer & Co reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
  • Bank Julius Baer & Co sold 217 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $107K.
  • Bank Julius Baer & Co first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 9 quarters.
  • Bank Julius Baer & Co's Bio-Rad Laboratories Class A position peaked at $1.29M in Q3 2021.
  • 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Bank Julius Baer & Co's 13F filing for Q3 2022, filed 4 Nov 2022.